Galderma Group AG (GALDY)
38.01
+0.25
(+0.66%)
USD |
OTCM |
Sep 14, 16:00
Galderma Group Market Cap : 44.32B for Sept. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 14, 2026 | 44.32B |
| September 11, 2026 | 44.03B |
| September 10, 2026 | 43.91B |
| September 09, 2026 | 44.62B |
| September 08, 2026 | 46.42B |
| September 04, 2026 | 45.51B |
| September 03, 2026 | 47.00B |
| September 02, 2026 | 47.50B |
| September 01, 2026 | 47.65B |
| August 31, 2026 | 48.26B |
| August 28, 2026 | 49.38B |
| August 27, 2026 | 49.55B |
| August 26, 2026 | 49.42B |
| August 25, 2026 | 49.95B |
| August 24, 2026 | 49.54B |
| August 21, 2026 | 49.91B |
| August 20, 2026 | 49.13B |
| August 19, 2026 | 50.24B |
| August 18, 2026 | 48.54B |
| August 17, 2026 | 48.57B |
| August 14, 2026 | 49.49B |
| August 13, 2026 | 51.22B |
| August 12, 2026 | 50.49B |
| August 11, 2026 | 50.46B |
| August 10, 2026 | 50.42B |
| Date | Value |
|---|---|
| August 07, 2026 | 52.36B |
| August 06, 2026 | 51.17B |
| August 05, 2026 | 51.32B |
| August 04, 2026 | 50.42B |
| August 03, 2026 | 50.10B |
| July 31, 2026 | 50.84B |
| July 30, 2026 | 52.58B |
| July 29, 2026 | 50.38B |
| July 28, 2026 | 50.43B |
| July 27, 2026 | 49.49B |
| July 24, 2026 | 49.54B |
| July 23, 2026 | 48.39B |
| July 22, 2026 | 49.70B |
| July 21, 2026 | 50.26B |
| July 20, 2026 | 49.74B |
| July 17, 2026 | 50.12B |
| July 16, 2026 | 49.14B |
| July 15, 2026 | 48.51B |
| July 14, 2026 | 48.71B |
| July 13, 2026 | 49.07B |
| July 10, 2026 | 50.15B |
| July 09, 2026 | 50.82B |
| July 08, 2026 | 51.02B |
| July 07, 2026 | 51.14B |
| July 06, 2026 | 51.93B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Sandoz Group AG | 35.19B |
| Novartis AG | 253.79B |
| Roche Holding AG | 302.53B |
| Addex Therapeutics Ltd. | 3.241M |
| Oculis Holding AG | 621.64M |
Market Cap Related Metrics
| PE Ratio | 51.88 |
| PS Ratio | 7.598 |
| Price to Free Cash Flow | 42.43 |
| Price | 38.01 |
| Earnings Yield | 1.93% |
| Operating PE Ratio | 41.00 |
| Normalized PE Ratio | 48.43 |